GLP-1 is actually a hormone naturally produced in your gut — specifically by L-cells in the intestinal lining. So it's no surprise that the relationship between GLP-1 medications and your gut microbiome is complex and bidirectional.
GLP-1 medications slow gastric emptying, which changes how quickly food reaches the colon and how gut bacteria interact with it. Early research suggests GLP-1 agonists may shift microbiome composition — increasing beneficial species associated with leanness and reducing pro-inflammatory bacteria.
Emerging evidence suggests that the diversity and composition of your microbiome may partly predict how well you respond to GLP-1 therapy. People with more diverse gut microbiomes may experience better outcomes — though this research is still evolving.
Nausea, constipation, and bloating from GLP-1 may partly relate to microbiome disruption. Gradual dietary changes, adequate hydration, and probiotic-rich foods can help ease the transition period.
Getting 100g+ of protein daily on a reduced appetite is hard. Strategic timing makes it more achievable — and more effective for muscle preservation.
Medication helps with appetite. But the mental skills for sustainable weight management — resilience, flexibility, self-compassion — must be built intentionally.
People who share their journey with a community — online or in person — consistently achieve better outcomes. Here's why, and where to find yours.